Home › Funds › RTW INVESTMENTS, LP › NGNE

RTW INVESTMENTS, LP position in NGNE

NEUROGENE INC · Health Care

RTW INVESTMENTS, LP reported holding 1,512,456 shares of NGNE (NEUROGENE INC) in its Q3 2026 13F filing — a position valued at US$42.1M, representing 0.42% of its reported portfolio and ranking #49 among its reported holdings. RTW INVESTMENTS, LP has disclosed NGNE holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)1.51M sh
Reported value held$42.08M
Portfolio Weight0.42%
First reportedQ1 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How RTW INVESTMENTS, LP's NGNE position evolved

RTW INVESTMENTS, LP first disclosed a stake in NGNE in Q1 2024 at 769,122 shares (US$39.1M). The position peaked in Q3 2024 at 1,135,256 shares, worth US$47.6M. Across 11 filings, RTW INVESTMENTS, LP increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 1,512,456 shares valued at US$42.1M — an increase of 150,000 shares quarter over quarter.. Notable position changes include a 39% increase in Q2 2024 (shares rose 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 769.12K $39.15M New
Q2 2024 1.07M $38.96M Add
Q3 2024 1.14M $47.64M Add
Q4 2024 1.35M $30.87M Add
Q1 2025 1.35M $15.79M Hold
Q2 2025 1.36M $20.37M Add
Q3 2025 1.36M $23.61M Hold
Q4 2025 1.36M $28.07M Hold
Q1 2026 1.36M $27.47M Hold
Q2 2026 1.36M $42.85M Hold
Q3 2026 1.51M $42.08M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NGNE and 13F data

NGNE (NEUROGENE INC) is a Health Care company. 39 other funds we track also report a position in NGNE — the largest reported positions include Samsara BioCapital, LLC (US$54.0M), Casdin Capital (US$48.6M), Redmile Group, LLC (US$44.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NGNE

All NGNE fund holders →

FAQ

How long has RTW INVESTMENTS, LP held NGNE?

RTW INVESTMENTS, LP has disclosed NGNE holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is RTW INVESTMENTS, LP's current position in NGNE?

As of Q3 2026, RTW INVESTMENTS, LP holds 1.51M shares of NGNE (NEUROGENE INC), valued at $42.08M, representing 0.42% of its reported portfolio and ranking #49.

Has RTW INVESTMENTS, LP been buying or selling NGNE?

In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP increased its position in NGNE. The position peaked in Q3 2024 at 1.14M shares.

Which other funds hold NGNE?

Other major institutional holders of NGNE include Samsara BioCapital, LLC, Casdin Capital, Redmile Group, LLC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.